Nuveen Asset Management, LLC Rigel Pharmaceuticals Inc Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 3,223,350 shares of RIGL stock, worth $25.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,223,350

Previous 2,466,668 30.68%

Holding current value

$25.1 Million

Previous $3.58 Million 33.39%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.12 - $1.57 $847,483 - $1.19 Million	756,682 Added 30.68%	3,223,350 $4.77 Million
Q4 2023 Feb 14, 2024	BUY	$0.72 - $1.56 $4,777 - $10,352	6,636 Added 0.27%	2,466,668 $3.58 Million
Q3 2023 Nov 14, 2023	BUY	$1.07 - $1.39 $2,946 - $3,828	2,754 Added 0.11%	2,460,032 $2.66 Million
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.82 $327,981 - $532,970	-292,841 Reduced 10.65%	2,457,278 $3.17 Million
Q1 2023 May 15, 2023	BUY	$1.25 - $2.0 $42,322 - $67,716	33,858 Added 1.25%	2,750,119 $3.63 Million

Q4 2022 Feb 14, 2023	BUY	$0.67 - $1.5 $307,389 - $688,185	458,790 Added 20.32%	2,716,261 $4.08 Million
Q3 2022 Nov 14, 2022	SELL	$1.1 - $1.72 $921,988 - $1.44 Million	-838,171 Reduced 27.08%	2,257,471 $2.66 Million
Q2 2022 Aug 15, 2022	SELL	$0.67 - $3.19 $704,035 - $3.35 Million	-1,050,799 Reduced 25.34%	3,095,642 $3.5 Million
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $806,395 - $1.25 Million	-363,241 Reduced 8.05%	4,146,441 $13.4 Million
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $1.07 Million - $1.61 Million	451,499 Added 11.13%	4,509,682 $12 Million
Q3 2021 Nov 12, 2021	SELL	$3.5 - $4.5 $380,957 - $489,802	-108,845 Reduced 2.61%	4,058,183 $14.7 Million
Q2 2021 Aug 16, 2021	BUY	$3.09 - $4.54 $2.69 Million - $3.95 Million	869,228 Added 26.36%	4,167,028 $18.1 Million
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $8.5 Million - $12.5 Million	2,538,392 Added 334.26%	3,297,800 $11.3 Million
Q4 2020 Feb 16, 2021	SELL	$2.35 - $3.74 $50,691 - $80,675	-21,571 Reduced 2.76%	759,408 $2.66 Million
Q3 2020 Nov 16, 2020	BUY	$1.78 - $4.13 $31,418 - $72,898	17,651 Added 2.31%	780,979 $1.87 Million
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $226,436 - $329,215	160,593 Added 26.64%	763,328 $1.4 Million
Q1 2020 May 14, 2020	SELL	$1.27 - $3.0 $24,975 - $58,998	-19,666 Reduced 3.16%	602,735 $940,000
Q3 2019 Nov 14, 2019	SELL	$1.63 - $2.62 $60,562 - $97,346	-37,155 Reduced 5.63%	622,401 $1.16 Million
Q2 2019 Aug 15, 2019	BUY	$2.02 - $2.61 $1.33 Million - $1.72 Million	659,556 New	659,556 $1.72 Million

Others Institutions Holding RIGL

# of Institutions

122

Shares Held

110M

Call Options Held

556K

Put Options Held

33.9K

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $1.34B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Rigel Pharmaceuticals Inc Transaction History